Unlock stock picks and a broker-level newsfeed that powers Wall Street. Upgrade Now
Shenzhen - Delayed Quote CNY

Hualan Biological Vaccine Inc. (301207.SZ)

Compare
17.88
-0.25
(-1.38%)
As of 12:47:31 PM GMT+8. Market Open.
Currency in CNY All numbers in thousands
Download
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Revenue
1,649,523.64
2,410,428.46
1,825,640.97
1,829,813.89
2,426,328.95
Cost of Revenue
269,402.98
287,097.74
217,451.49
220,760.73
257,939.20
Gross Profit
1,380,120.66
2,123,330.72
1,608,189.48
1,609,053.16
2,168,389.75
Operating Expense
821,511.43
1,090,768.52
855,961.59
793,886.96
1,023,009.97
Operating Income
558,609.24
1,032,562.19
752,227.89
815,166.20
1,145,379.78
Net Non Operating Interest Income Expense
9,263.26
5,248.67
5,589.65
-8,452.40
-880.36
Pretax Income
577,854.38
1,006,881.12
589,478.84
705,749.49
1,074,054.06
Tax Provision
80,240.89
146,912.52
69,844.03
84,777.07
149,144.93
Net Income Common Stockholders
497,613.49
859,968.60
519,634.80
620,972.41
924,909.13
Basic EPS
0.83
1.43
0.88
1.15
1.71
Diluted EPS
0.82
1.43
0.88
1.15
1.71
Basic Average Shares
599,987.66
600,704.53
590,024.76
540,007.32
539,998.32
Diluted Average Shares
601,712.98
602,429.84
590,427
540,007.32
539,998.32
Total Operating Income as Reported
578,420.04
1,010,057.25
592,633.93
706,976.27
1,074,089.71
Total Expenses
1,090,914.41
1,377,866.27
1,073,413.07
1,014,647.69
1,280,949.16
Net Income from Continuing & Discontinued Operation
497,613.49
859,968.60
519,634.80
620,972.41
924,909.13
Normalized Income
552,167.91
943,684.92
714,156.82
729,855.62
992,678.74
Interest Income
15,375.91
11,435.82
16,411.27
5,057.66
1,347.52
Interest Expense
6,100
6,083.33
10,693.07
13,315.82
1,996.74
Net Interest Income
9,263.26
5,248.67
5,589.65
-8,452.40
-880.36
EBIT
583,954.38
1,012,964.45
600,171.91
719,065.31
1,076,050.79
EBITDA
583,954.38
1,153,293.08
735,604.85
787,993.88
1,116,896.12
Reconciled Cost of Revenue
269,402.98
287,097.74
217,451.49
220,760.73
257,939.20
Reconciled Depreciation
--
140,328.63
135,432.94
68,928.57
40,845.33
Net Income from Continuing Operation Net Minority Interest
497,613.49
859,968.60
519,634.80
620,972.41
924,909.13
Total Unusual Items Excluding Goodwill
-63,351.40
-98,017.98
-220,667.68
-123,748.28
-78,697.70
Total Unusual Items
-63,351.40
-98,017.98
-220,667.68
-123,748.28
-78,697.70
Normalized EBITDA
647,305.78
1,251,311.06
956,272.54
911,742.16
1,195,593.82
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
-8,796.98
-14,301.66
-26,145.67
-14,865.07
-10,928.09
12/31/2020 - 2/18/2022

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

600161.SS TIANTAN BIO
20.13
+0.15%
 
096530.KQ Seegene, Inc.
24,700.00
+0.20%
 
WXIBF WuXi Biologics (Cayman) Inc.
2.9100
0.00%
 
IVBIY Innovent Biologics Inc.
19.15
0.00%
 
214450.KQ PharmaResearch Co., Ltd.
295,500.00
+0.51%
 
IVBXF Innovent Biologics, Inc.
5.51
+0.20%
 
CLVLY Clinuvel Pharmaceuticals Limited
7.17
0.00%
 
ANL Adlai Nortye Ltd.
2.2203
+0.92%
 
SVA Sinovac Biotech Ltd.
6.47
0.00%
 
AVTE Aerovate Therapeutics, Inc.
2.4300
+0.83%